Luis Fernando Granados Castro - Uhthoff

Regulatory Certainty Strategy for Biosimilar Drugs in Mexico

Mexico has been continuously facing the new challenges related to the growing biotechnology industry. Mexican authorities have recognized that the current regulation does not generate the ideal conditions to allow the effective entry (from the clinical phase to obtaining marketing authorizations) of new innovative treatments, biosimilars or interchangeable generics. Since November 2021, Mexico was accepted […]

Accelerated Patent Grant (AGP) agreement between IMPI-USPTO as a new complement for optimizing patent prosecution in Mexico.

Mexican Institute of Industrial Property (IMPI) has been focusing efforts in reducing timeframe for patent prosecution in Mexico, considering available foreign work products, efforts, and analysis. Increasing the possibilities for applicants to accelerate patent prosecution time takes high relevance when considering the provision of Article 126 of Federal Law for Protection of Industrial Property (FLPIP), […]

Mexican Institute of Industrial Property (IMPI) and European Patent Office (EPO) strategic cooperation enhancing patent-prosecution strategies in Mexico in terms of pharmaceutical patents.

Mexico is the leading country in exports of pharmaceutical products in Latin-American. The pharmaceutical sector in Mexico is considered one of the top ten industries interested in patent protection for its products, processes or uses. From the available current data of the IMPI and World Intellectual Property Organization (WIPO), the main technical field of filed […]